Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani

NCT07311876 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-13

No results posted yet for this study

Summary

The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during open lymphatic reconstruction in the head and neck.

Conditions

  • Lymphedema
  • Lymphedema of Face
  • Internal Lymphedema
  • External Lymphedema
  • Lymphedema of Neck

Interventions

DEVICE

Symani Surgical System

Symani® Surgical System is intended to perform surgical techniques during open microsurgical procedures.

Sponsors & Collaborators

  • MMI (Medical Microinstruments, Inc.)

    lead INDUSTRY

Principal Investigators

  • Martin Laudien · University Hospital Schleswig-Holstein

  • Jamie Ku · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-19
Primary Completion
2027-08-01
Completion
2028-02-01
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07311876 on ClinicalTrials.gov